Crispo, J. A. G., Farhat, N., Fortin, Y., Pérez Lloret, S., Sikora, L., Morgan, R. L., . . . Krewski, D. (2024). Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson’s disease. Web
Citación estilo ChicagoCrispo, James A. G., et al. Non-ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease. 2024.
Cita MLACrispo, James A. G., et al. Non-ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease. 2024.
Precaución: Estas citas no son 100% exactas.